 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 May 2001 | Volume 134 Issue 10 | Pages 968-977
Background: Poor adherence to HIV protease inhibitors may compromise the effectiveness of treatment. Few studies have compared methods for measuring adherence or have related adherence measures to a clinical outcome.
Objective: To examine the relationship among a composite score of adherence, the three primary measures of adherence, and HIV virologic response.
Design: Longitudinal cohort study.
Setting: Public HIV clinic.
Patients: 108 HIV-infected adults receiving protease inhibitors or non-nucleoside reverse transcriptase inhibitors who were monitored for 666 monthly intervals.
Measurements: Medication Event Monitoring System (MEMS), pill count, and interview combined into a composite adherence score (CAS), and HIV viral load.
Results: Mean antiretroviral adherence differed by adherence measure (MEMS, 0.63; pill count, 0.83; interview, 0.93; and CAS, 0.76). Composite adherence score decreased significantly over time. Composite adherence score, MEMS values, pill values, and interview values were statistically significantly associated with achievement of an undetectable viral load within 6 months of initiating therapy. Composite adherence score showed the strongest predictive relationship (odds ratios for a 10% increase in adherence for CAS, MEMS, pill count, and interview, respectively, were 1.26 [95% CI, 1.16 to 1.37], 1.13 [CI, 1.06 to 1.21], 1.10 [CI, 1.02 to 1.19], and 1.35 [CI, 0.94 to 1.94]).
Conclusions: Different measures applied to the same patient suggest different levels of adherence. Adherence may be underestimated by MEMS and overestimated by pill count and interview. A summary measure combining several measures is more strongly related to a clinical response, but more practical measurement methods are needed for clinical use.
Author and Article Information
From the University of California, Los Angeles, Los Angeles, and Sheps Center for Health Services Research, Harbor–University of California, Los Angeles, Medical Center, Torrance, California; and University of North Carolina at Chapel Hill and Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Acknowledgment: The authors acknowledge Victor Gonzalez for technical assistance.
Grant Support: By the National Institute for Allergy and Infectious Diseases (R01 AI 41413).
Requests for Single Reprints: Honghu Liu, PhD, Division of General Internal Medicine and Health Service Research, 911 Broxton Plaza, Room 102, Box 951736, Los Angeles, CA 90095-1736; email, hhliu{at}ucla.edu.
Current Author Addresses: Dr. Liu: Division of General Internal Medicine and Health Service Research, 911 Broxton Plaza, Room 102, Los Angeles, CA 90095-1736.
Dr. Golin: University of North Carolina Sheps Center for Health Services Research, 725 Airport Road, Suite 208, Campus Box 7590, Chapel Hill, NC 27599-7590.
Dr. Miller: Division of Infectious Diseases, Harbor–University of California, Los Angeles, Medical Center, 1124 West Carson Street, Box 466, Torrance, CA 90509.
Dr. Hays: Division of General Internal Medicine and Health Service Research, 911 Broxton Plaza, Room 110, Los Angeles, CA 90095-1736.
Dr. Beck, Ms. Christian, Ms. Maldonado, and Ms. Duran: Division of Allergy and Clinical Immunology, Harbor–University of California, Los Angeles, Medical Center, 1124 West Carson Street, N-24, Torrance, CA 90502.
Mr. Sanandaji: Division of General Internal Medicine and Health Service Research, 911 Broxton Plaza, Los Angeles, CA 90095-1736.
Dr. Kaplan: 547 Burnett Womack, Campus Box 7030, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7030.
Dr. Wenger: Division of General Internal Medicine and Health Service Research, 911 Broxton Plaza, Room 205, Los Angeles, CA 90095-1736. ACADEMIA AND CLINIC
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  G. S. Zaric, A. M. Bayoumi, M. L. Brandeau, and D. K. Owens The Cost-Effectiveness of Counseling Strategies to Improve Adherence to Highly Active Antiretroviral Therapy among Men Who Have Sex with Men Med Decis Making, June 1, 2008; 28(3): 359 - 376. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Chisholm-Burns and C. A. Spivey Pharmacoadherence: A new term for a significant problem Am. J. Health Syst. Pharm., April 1, 2008; 65(7): 661 - 667. [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Modi, D. A. Morita, and T. A. Glauser One-Month Adherence in Children With New-Onset Epilepsy: White-Coat Compliance Does Not Occur Pediatrics, April 1, 2008; 121(4): e961 - e966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Cuevas Gonzalez, L. O. Valin, M. d. R. Perez-Simon, J. L. Mostaza Fernandez, M. Alcoba Leza, V. M. Sanchez, and the HAART Adherence Working Group of the Province A Prospective Study of Adherence and Virologic Failure in HIV-Infected Patients: Role of a Single Determination of Plasma Levels of Antiretroviral Medications J Int Assoc Physicians AIDS Care (Chic Ill), December 1, 2007; 6(4): 245 - 250. [Abstract] [PDF]
|
|
|
|
 |
|
 S. R Smith, A. S Wahed, S. S Kelley, H. S Conjeevaram, P. R Robuck, M. W Fried, and Virahep-C Study Group Assessing the Validity of Self-Reported Medication Adherence in Hepatitis C Treatment Ann. Pharmacother., July 1, 2007; 41(7): 1116 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Murphy, W. D. Marelich, N. B. Rappaport, D. Hoffman, and C. Farthing Results of an Antiretroviral Adherence Intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly) J Int Assoc Physicians AIDS Care (Chic Ill), June 1, 2007; 6(2): 113 - 124. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Denhaerynck, D. Manhaeve, F. Dobbels, D. Garzoni, C. Nolte, and S. De Geest PREVALENCE AND CONSEQUENCES OF NONADHERENCE TO HEMODIALYSIS REGIMENS Am. J. Crit. Care., May 1, 2007; 16(3): 222 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Wong, K. Robertson, N. Nakasujja, R. Skolasky, S. Musisi, E. Katabira, J. C. McArthur, A. Ronald, and N. Sacktor Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa Neurology, January 30, 2007; 68(5): 350 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Braithwaite, S. Shechter, M. S. Roberts, A. Schaefer, D. R. Bangsberg, P. R. Harrigan, and A. C. Justice Explaining variability in the relationship between antiretroviral adherence and HIV mutation accumulation J. Antimicrob. Chemother., November 1, 2006; 58(5): 1036 - 1043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Smith, J. A. Krishnan, A. Bilderback, K. A. Riekert, C. S. Rand, and S. J. Bartlett Depressive symptoms and adherence to asthma therapy after hospital discharge. Chest, October 1, 2006; 130(4): 1034 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Mills, J. B. Nachega, I. Buchan, J. Orbinski, A. Attaran, S. Singh, B. Rachlis, P. Wu, C. Cooper, L. Thabane, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA, August 9, 2006; 296(6): 679 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jasti, A. M. Siega-Riz, M. E. Cogswell, and A. G. Hartzema Correction for Errors in Measuring Adherence to Prenatal Multivitamin/Mineral Supplement Use among Low-Income Women J. Nutr., February 1, 2006; 136(2): 479 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. George, D. C. M. Kong, R. Thoman, and K. Stewart Factors Associated With Medication Nonadherence in Patients With COPD Chest, November 1, 2005; 128(5): 3198 - 3204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Paasche-Orlow, K. A. Riekert, A. Bilderback, A. Chanmugam, P. Hill, C. S. Rand, F. L. Brancati, and J. A. Krishnan Tailored Education May Reduce Health Literacy Disparities in Asthma Self-Management Am. J. Respir. Crit. Care Med., October 15, 2005; 172(8): 980 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Osterberg and T. Blaschke Adherence to Medication N. Engl. J. Med., August 4, 2005; 353(5): 487 - 497. [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Phillips, L. Moneyham, C. Murdaugh, M. R. Boyd, A. Tavakoli, K. Jackson, and M. Vyavaharkar Sleep Disturbance and Depression as Barriers to Adherence Clin Nurs Res, August 1, 2005; 14(3): 273 - 293. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Hardy Adherence to Antiretroviral Therapy: The Emerging Role of HIV Pharmacotherapy Specialists Journal of Pharmacy Practice, August 1, 2005; 18(4): 247 - 257. [Abstract] [PDF]
|
|
|
|
|
|
B. Vrijens and J. Urquhart Patient adherence to prescribed antimicrobial drug dosing regimens J. Antimicrob. Chemother., May 1, 2005; 55(5): 616 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Vrijens, E. Tousset, R. Rode, R. Bertz, S. Mayer, and J. Urquhart Successful Projection of the Time Course of Drug Concentration in Plasma During a 1-Year Period From Electronically Compiled Dosing-Time Data Used as Input to Individually Parameterized Pharmacokinetic Models J. Clin. Pharmacol., April 1, 2005; 45(4): 461 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Kilbourne, C. F. Reynolds III, C. B. Good, S. M. Sereika, A. C. Justice, and M. J. Fine How Does Depression Influence Diabetes Medication Adherence in Older Patients? Am J Geriatr Psychiatry, March 1, 2005; 13(3): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. W. R. Cheng, K.-s. Woo, J. C. N. Chan, B. Tomlinson, and J. H. S. You Assessing adherence to statin therapy using patient report, pill count, and an electronic monitoring device Am. J. Health Syst. Pharm., February 15, 2005; 62(4): 411 - 415. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kilbourne, C. B. Good, S. M. Sereika, A. C. Justice, and M. J. Fine Algorithm for assessing patients' adherence to oral hypoglycemic medication Am. J. Health Syst. Pharm., January 15, 2005; 62(2): 198 - 204. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wood, R. S. Hogg, B. Yip, P. R. Harrigan, M. V. O'Shaughnessy, and J. S.G. Montaner Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 x 109 cells/L Ann Intern Med, November 18, 2003; 139(10): 810 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. W. Grant, N. G. Devita, D. E. Singer, and J. B. Meigs Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes Diabetes Care, May 1, 2003; 26(5): 1408 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.H. Hinkin, S.A. Castellon, R.S. Durvasula, D.J. Hardy, M.N. Lam, K.I. Mason, D. Thrasher, M.B. Goetz, and M. Stefaniak Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity Neurology, December 24, 2002; 59(12): 1944 - 1950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Bies, M. R. Gastonguay, K. C. Coley, P. D. Kroboth, and B. G. Pollock Evaluating the Consistency of Pharmacotherapy Exposure by Use of State-of-the-Art Techniques Am J Geriatr Psychiatry, December 1, 2002; 10(6): 696 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Liu, A. Kaplan, and N. Wenger Measuring Patient Adherence Ann Intern Med, July 2, 2002; 137(1): 72 - 72. [Full Text] [PDF]
|
|
|
|
|
|
E. B. Fisher, E. A. Walker, A. Bostrom, B. Fischhoff, D. Haire-Joshu, and S. B. Johnson Behavioral Science Research in the Prevention of Diabetes : Status and opportunities Diabetes Care, March 1, 2002; 25(3): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. Elwood 'The Head that Doesn't Speak One Calls a Cabbage:' Hiv, Aids, Risk, and Social Support in the 21St Century Journal of Social and Personal Relationships, February 1, 2002; 19(1): 143 - 149. [Abstract] [PDF]
|
|
|
|
|
|
Correction: Multiple Measures of Adherence to HIV Protease Inhibitors Ann Intern Med, January 15, 2002; 136(2): 175 - 175. [Full Text] [PDF]
|
|
|
|
 |
|
 Adherence By Any Measure Still Matters AIDS Clinical Care, July 1, 2001; 2001(701): 1 - 1. [Full Text]
|
|
|
|
|
|
B. J. Turner and F. M. Hecht Improving on a Coin Toss To Predict Patient Adherence to Medications Ann Intern Med, May 15, 2001; 134(10): 1004 - 1006. [Full Text] [PDF]
|
|
Article
